Sign in
CompletedNo phase

Mindfulness Program for Blood Sugar Control, Heart Rate Variability, Anxiety, and Depression in Type 2 Diabetes

Key facts

Who runs it
Universitas Sebelas Maret Hospital
Where
Indonesia1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
28 people enrolled
Started
1 Mar 2025
Ended
30 Jun 2025
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Six-week audio-guided mindfulness program
Record updated
13 November 2026

Who can take part

Age
18 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Adults aged 18-60 years with type 2 diabetes mellitus
  • Receiving antidiabetic treatment
  • Attending the Internal Medicine Outpatient Clinic of Dr. Moewardi General Hospital
  • Willing to participate and provided written informed consent

Who cannot take part

  • Coffee consumption within 1 week before the start of the study
  • Thyroid disorders
  • Cardiac arrhythmia
  • Use of drugs that may affect heart rate variability (e.g., beta-blockers, antidepressants, antipsychotics, or anxiolytics)
  • Anemia (hemoglobin <13 g/dL in men or <12 g/dL in women)
  • Pregnancy or breastfeeding

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial was to learn whether a six-week mindfulness program, added to standard diabetes treatment, improves blood sugar control, heart rate variability (a measure of how the nervous system regulates the heart), anxiety, and depression in adults aged 18 to 60 years with type 2 diabetes. The main questions it aimed to answer were:

Read full original descriptionShow less

* Does the mindfulness program lower glycated hemoglobin (HbA1c), fasting blood glucose, and 2-hour postprandial blood glucose? * Does it improve heart rate variability, cardiovascular autonomic dysfunction status, and anxiety and depression scores?

Researchers compared participants who received standard therapy plus the mindfulness program with participants who received standard therapy alone.

Participants in the mindfulness group listened to weekly audio-guided practices sent through WhatsApp (mindful eating, breathing exercise, body scan, mindful walking, dealing with unpleasant experiences, and loving-kindness meditation) and were asked to practice daily for six weeks. All participants had blood tests, a 3-minute heart rate variability recording, and the Hospital Anxiety and Depression Scale questionnaire at the start of the study and after six weeks.

The 2 groups in the trial

  • Mindfulness plus standard therapyTreatment being tested

    Participants continued their standard antidiabetic therapy and completed a six-week audio-guided mindfulness program delivered through WhatsApp.

    Treatment: Six-week audio-guided mindfulness program

  • Standard therapyNo study treatment, for comparison

    Participants continued their standard antidiabetic therapy without the mindfulness program.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of a Six-Week Mindfulness-Based Intervention on Glycemic Control, Cardiovascular Autonomic Function, Anxiety, and Depression in Adults With Type 2 Diabetes: A Randomized Controlled Trial
Record updated
13 November 2026